Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,181 total articles
Amaze Holdings, Inc. announced Amaze Commerce, a new operating system designed to revolutionize revenue generation in the creator economy by using AI-powered Moments AI to convert social engagement signals into product ideas. The platform enables creators to launch products faster with higher success rates by focusing on audience behavior and engag…
Founder Group Limited announced the award of an additional RM34 million (approximately US$8.6 million) EPC contract for a 9.5 MW solar facility under Malaysia’s LSS5 programme. This expands the company's total contracts under LSS5 to RM70 million (approximately US$17.7 million). The project is planned to achieve commercial operation by May 2027 and…
Cycurion, Inc., a cybersecurity and AI-driven solutions provider, announced two new multi-year contract awards in the public health sector expected to generate approximately $1.35 million in revenue in 2026, including $1.165 million in new annual recurring revenue. These awards expand their footprint in secure cloud-based public health systems and …
INVO Fertility, a NASDAQ-listed healthcare company specializing in fertility treatments and technology, will implement a 1-for-5 reverse stock split effective March 27, 2026. This move will reduce the total number of outstanding shares to approximately 1.6 million while maintaining the same ticker symbol, IVF, on Nasdaq. The company focuses on intr…
Micron Technology, Inc. has announced offers to repurchase for cash various outstanding senior notes totaling several billion dollars. The tender offers cover notes maturing between 2031 and 2036, with the offers expiring on March 31, 2026, and expected settlement around April 3, 2026. The company reserves rights to amend or terminate the offers an…
3D Systems has secured full-scope European Union Medical Device Regulation (EU MDR) certification, authorizing the launch of its NextDent Jetted Denture Solution across European markets targeted for summer 2026. Building on its 2025 US launch success, this move expands the company's digital dentistry footprint into significant European markets. The…
YY Group Holding Limited announced its estimated total assets of approximately $34.3 million ($8.03 per share) and net assets of approximately $13.6 million ($3.18 per share) for fiscal year 2025, reflecting preliminary unaudited results. The company accelerated growth via AI and robotics integration, secured major multi-year contracts internationa…
Verisk and APCIA released preliminary 2025 U.S. property and casualty insurance underwriting results showing a significant improvement with a $63 billion net underwriting gain, up from $23 billion in 2024. The strong performance was driven primarily by an unusually low level of catastrophe losses, particularly a sharp decline in hurricane-related c…
SL Green Realty Corp. refinances One Madison Avenue with a $1.65 billion fixed-rate loan at 5.81%, replacing its previous $1.25 billion construction loan. The transaction, led by Wells Fargo and featuring major banks, is oversubscribed and reflects strong investor demand for high-quality office properties despite market volatility. The refinancing …
IMUNON announced updated final data from its Phase 2 OVATION 2 trial showing that treatment with IMNN-001 combined with standard chemotherapy significantly improved median overall survival in women with newly diagnosed advanced ovarian cancer, especially when combined with PARP inhibitors. Enrollment in the pivotal Phase 3 OVATION 3 trial is ahead …
Safe Pro Group Inc., a Nasdaq-listed company specializing in AI-enabled defense and security solutions, announced the appointment of Brian Mack, former Anduril Senior Business Development Director and Retired U.S. Army Officer, to its Strategic Advisory Board. Mack brings extensive defense acquisition expertise and a strong network within the U.S. …
CDT Equity Inc. (NASDAQ: CDT) announced a 1-for-25 reverse stock split effective March 26, 2026. This corporate action reduces the number of outstanding shares to roughly 4.72 million, with no change in the par value per share. The move, approved by both the board and shareholders, intends to adjust the share structure and maintain listing standard…
Linkers Industries Limited (Nasdaq: LNKS) announced a non-binding Memorandum of Understanding to acquire up to 29% equity in LPW Electronics Co. Ltd., a wire harness manufacturer in Thailand, increasing its stake to 49%. The acquisition aims to boost Linkers' manufacturing capacity, optimize economies of scale, and broaden its customer base, suppor…
Aemetis, Inc. announced that CEO Eric McAfee received the 2026 William C. Holmberg Memorial Award for Lifetime Achievement in the Bioeconomy. The award honors McAfee's longstanding leadership and contributions to renewable fuels and bioeconomy innovation. Aemetis is actively expanding its renewable natural gas, biofuels, sustainable aviation fuel, …
Purple Biotech announced a collaboration with AI-driven drug discovery company Converge Bio to accelerate and optimize its next-generation tri-specific antibody platform aimed at cancer treatment. The partnership leverages Converge Bio's generative AI technology to speed up molecule design, improve candidate quality, and expand the company's immuno…
ProMIS Neurosciences completed enrollment of 144 patients in its PRECISE-AD Phase 1b trial for Alzheimer’s disease, with positive safety results to date and anticipated interim data in Q3 2026 and top-line results in early 2027. The company secured up to $175 million in financing ensuring cash runway through 2027, accelerating development of a subc…
AEON Biopharma announced positive feedback from the FDA following their January 2026 Biosimilar Biological Product Development Type 2a meeting regarding the analytical similarity strategy for ABP-450, their biosimilar candidate to BOTOX®. The FDA recognized the scientific challenges but supported AEON's analytical approach under the 351(k) biosimil…
Catheter Precision, Inc. (NYSE American: VTAK) announced the expansion of its Flyte subsidiary's Vision Jet-powered Hops platform, aimed at creating a scalable, high-frequency short-haul regional travel solution. Flyte operates Cirrus Vision Jets optimized for under-500-mile routes, offering safety features like full-aircraft parachutes and autonom…
Aduro Clean Technologies Inc. has entered into a professional agreement with Water Tower Research LLC to receive research coverage and strategic investor engagement services aimed at increasing the company's visibility within institutional investment communities in the U.S. and internationally. The contract includes production of content and distri…
Avalyn Pharma announced peer-reviewed data from its Phase 1b ATLAS trial demonstrating that improvements in quantitative lung imaging correlate with better lung function and quality of life in patients with idiopathic pulmonary fibrosis treated with AP01. The findings mark the first dataset linking antifibrotic therapy imaging with clinical outcome…
Innovation Beverage Group Ltd. (Nasdaq: IBG) announced it has acquired a 51% controlling stake in Texas-based BlockFuel Energy Inc. This acquisition is a significant milestone toward a proposed merger that will create a rising oil producer and power generation company focusing on US onshore oil and gas operations and power generation for high-perfo…
ProQR Therapeutics announced a virtual investor and analyst event on April 8, 2026, to showcase its expanding RNA editing pipeline based on its proprietary Axiomer™ technology. The company plans to provide updates on the lead AX-0810 program targeting cholestatic diseases with anticipated initial Phase 1 data in the first half of 2026, unveil AX-08…
Incannex Healthcare has entered a partnership with the American Academy of Sleep Medicine Foundation to sponsor research in sleep apnea, reflecting its commitment to the field as it advances its lead investigational oral combination therapy, IHL-42X. The company recently achieved strong Phase 2 clinical results and received FDA Fast Track designati…
authID announced a strategic OEM partnership with a disruptive digital identity and continuous background screening tech company to embed its biometric identity verification and authentication technology into the partner's platform. This collaboration aims to provide organizations with reusable digital identity credentials that enable secure onboar…
LB Pharmaceuticals has commenced its pivotal Phase 3 NOVA-2 trial to evaluate LB-102, a novel oral benzamide antipsychotic candidate, for the treatment of schizophrenia in approximately 460 U.S. patients. LB-102 showed promising Phase 2 results with significant symptom improvement and a favorable safety profile. Topline data from NOVA-2 are expecte…
